Cargando…
Tissue Biomarkers in Melanoma Patients Treated with TIL
While treating stage III melanoma patients with autologous therapeutic TIL in an adjuvant setting, we previously reported a significant benefit of treatment on both progression-free survival and overall survival in patients with only one invaded lymph node (early stage III) compared to patients with...
Autores principales: | Knol, Anne-Chantal, Nguyen, Jean-Michel, Pandolfino, Marie-Christine, Quéreux, Gaëlle, Brocard, Anabelle, Peuvrel, Lucie, Saint-Jean, Mélanie, Saiagh, Soraya, Khammari, Amir, Dréno, Brigitte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527474/ https://www.ncbi.nlm.nih.gov/pubmed/23284620 http://dx.doi.org/10.1371/journal.pone.0048729 |
Ejemplares similares
-
Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes in Advanced Melanoma Patients
por: Saint-Jean, Mélanie, et al.
Publicado: (2018) -
Adoptive TIL Transfer in the Adjuvant Setting for Melanoma: Long-Term Patient Survival
por: Khammari, Amir, et al.
Publicado: (2014) -
Chemotherapy efficacy after first-line immunotherapy in 18 advanced melanoma patients
por: Saint-Jean, Mélanie, et al.
Publicado: (2020) -
Dramatic response of an inoperable Merkel cell carcinoma with imatinib
por: Frenard, Cecile, et al.
Publicado: (2016) -
Visceral metastatic angiosarcoma treated effectively with oral cyclophosphamide combined with propranolol
por: Daguzé, Justine, et al.
Publicado: (2016)